ArticleThoracic cancer2019
Equibalancing immune-related adverse events and anticancer activity of immune checkpoint inhibitors.
Sharvesh Raj SeeruttunPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it